Notizie dei mercati

Sarepta Therapeutics, Inc.: Guggenheim rimane Buy

This content has been archived. It may no longer be relevant

Sarepta Therapeutics, Inc.: Guggenheim rimane Buy

Sarepta Therapeutics Guggenheim


FIMA2614# 2022-08-03T17:01:39+02:00

Show More